Poramed Winichakoon
Overview
Explore the profile of Poramed Winichakoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winichakoon P, Watcharasaksilp K, Butphet S, Wongworapat K, Pantip C, Khamnoi P, et al.
Sci Rep
. 2025 Jan;
15(1):3675.
PMID: 39881189
Early diagnosis and appropriate treatment are essential for reducing morbidity and mortality in tuberculous meningitis (TBM). This study aimed to evaluate the diagnostic performance of the Xpert MTB/RIF assay for...
2.
Louthrenoo W, Tangkum P, Kasitanon N, Gumtorntip W, Winichakoon P, Konsamun S, et al.
Vaccines (Basel)
. 2025 Jan;
12(12.
PMID: 39772059
: To compare disease activity and flares among different doses and types of COVID-19 vaccines in systemic lupus erythematosus (SLE) patients. SLE patients in a lupus cohort, who received at...
3.
Winichakoon P, Solera Rallo J, Albasata H, Poutanen S, Hosseini-Moghaddam S
Transpl Infect Dis
. 2024 Dec;
:e14417.
PMID: 39692600
Background: A considerable knowledge gap exists in predicting severe Pneumocystis pneumonia (PCP) outcomes following PCP diagnosis. Methods: In this retrospective cohort, we studied immunocompromised patients with PCP admitted to 5...
4.
Tangkum P, Kasitanon N, Gumtorntip W, Winichakoon P, Konsamun S, Wongthanee A, et al.
Int J Rheum Dis
. 2024 Dec;
27(12):e70001.
PMID: 39655469
Objectives: To compare adverse events and flares among different doses and types of COVID-19 vaccines in patients with systemic lupus erythematosus (SLE). Methods: All consecutive SLE patients in a lupus...
5.
Tidwong N, Chanruang A, Chupradit S, Parker S, Leelawattanachai P, Winichakoon P, et al.
Clin Transl Sci
. 2024 Sep;
17(10):e70038.
PMID: 39347794
Fosfomycin has been used to treat carbapenem-resistant Acinetobacter baumannii (CRAB) infections. However, there is insufficient information on dosage adjustment among critically ill patients with renal impairment. This study aims to...
6.
Phuensan P, Sirimongkolkasem J, Tantawichien T, Phannajit J, Kerr S, Hansasuta P, et al.
Heliyon
. 2024 Jan;
10(1):e23246.
PMID: 38163241
Background: During the peak of Coronavirus disease (COVID-19) pandemic in Thailand when the emergence of delta variant reduced the efficacy of inactivated vaccine, Thailand had abundance of inactivated vaccine but...
7.
Chaiwarith R, Winichakoon P, Salee P, Sudjaritruk T, Wipasa J, Chawansuntati K, et al.
Sci Rep
. 2023 Nov;
13(1):19736.
PMID: 37957189
This study followed healthcare personnel (HCP) who had completed a primary series of CoronaVac and then received the third and fourth doses of COVID-19 vaccine. The primary objective was to...
8.
Narongkiatikhun P, Noppakun K, Chaiwarith R, Winichakoon P, Vongsanim S, Suteeka Y, et al.
Vaccines (Basel)
. 2023 Oct;
11(10).
PMID: 37897029
The authors wish to make the following correction to this paper [...].
9.
Narongkiatikhun P, Noppakun K, Chaiwarith R, Winichakoon P, Vongsanim S, Suteeka Y, et al.
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112627
Background: Vaccines that prevent SARS-CoV-2 infection are considered the most promising approach to modulating the pandemic. There is scarce evidence on the efficacy and safety of different vaccine prime-boost combinations...
10.
Sudjaritruk T, Mueangmo O, Saheng J, Winichakoon P, Salee P, Wongjak W, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992147
To compare immunogenicity and reactogenicity of five COVID-19 vaccine regimens against wild-type SARS-CoV-2 and variants of concern (VoCs) among Thai populations, a prospective cohort study was conducted among healthy participants...